Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00818961 · OUTCOME

Non-relapse Mortality at 1 Year Post-transplant

Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer · Source last updated 2013-12-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
participants
Interval / dispersion
Not reported
Time frame
1 year

What was measured

Number of patients who died of non-relapse causes at one year. this is in clusive of all patients who were transplanted on study even though only 10 patients died at by 1 year time point. This outcome will be referenced in the donor chimerism outcome. Only 26/36 patients were eligible for this time point as that is all that were alive.

Analysis population: 36 patients underwent hematopoietic stem cell transplant. 10 patients died prior to 1 year post-transplant and were eligible for evaluation of non-relapse mortality at 1 year post-transplant

Groups in this outcome

Hematopoietic Stem Cell Transplantation

All patients receive a hematopoietic stem cell transplant using one of two chemotherapy regimens based on disease type

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Hematopoietic Stem Cell Transplantation36

Reported measurements

Source class 1
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Hematopoietic Stem Cell Transplantation4Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        4
denoms
  1. counts
    1. group Id
      OG000
      value
      36
    units
    Participants
description
Number of patients who died of non-relapse causes at one year. this is in clusive of all patients who were transplanted on study even though only 10 patients died at by 1 year time point. This outcome will be referenced in the donor chimerism outcome. Only 26/36 patients were eligible for this time point as that is all that were alive.
groups
  1. description
    All patients receive a hematopoietic stem cell transplant using one of two chemotherapy regimens based on disease type
    id
    OG000
    title
    Hematopoietic Stem Cell Transplantation
param Type
NUMBER
population Description
36 patients underwent hematopoietic stem cell transplant. 10 patients died prior to 1 year post-transplant and were eligible for evaluation of non-relapse mortality at 1 year post-transplant
reporting Status
POSTED
time Frame
1 year
title
Non-relapse Mortality at 1 Year Post-transplant
type
SECONDARY
unit Of Measure
participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice